IDEAS home Printed from https://ideas.repec.org/a/spr/drugsa/v39y2016i7d10.1007_s40264-016-0420-2.html
   My bibliography  Save this article

Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment

Author

Listed:
  • Elise J. Smolders

    (Radboud university medical center)

  • Clara T. M. M. Kanter

    (University Medical Center Utrecht)

  • Bart Hoek

    (Leids University Medical Center)

  • Joop E. Arends

    (University Medical Center Utrecht)

  • Joost P. H. Drenth

    (Radboud university medical center)

  • David M. Burger

    (Radboud university medical center)

Abstract

Hepatitis C virus (HCV)-infected patients often suffer from liver cirrhosis, which can be complicated by renal impairment. Therefore, in this review we describe the treatment possibilities in HCV patients with hepatic and renal impairment. Cirrhosis alters the structure of the liver, which affects drug-metabolizing enzymes and drug transporters. These modifications influence the plasma concentration of substrates of drugs metabolized/transported by these enzymes. The direct-acting antivirals (DAAs) are substrates of, for example, cytochrome P450 enzymes in the liver. Most DAAs are not studied in HCV-infected individuals with decompensated cirrhosis, and therefore awareness is needed when these patients are treated. Most DAAs are contraindicated in cirrhotic patients; however, patients with a Child-Pugh score of B or C can be treated safely with a normal dose sofosbuvir plus ledipasvir or daclatasvir, in combination with ribavirin. Patients with renal impairment (glomerular filtration rate [GFR]

Suggested Citation

  • Elise J. Smolders & Clara T. M. M. Kanter & Bart Hoek & Joop E. Arends & Joost P. H. Drenth & David M. Burger, 2016. "Pharmacokinetics, Efficacy, and Safety of Hepatitis C Virus Drugs in Patients with Liver and/or Renal Impairment," Drug Safety, Springer, vol. 39(7), pages 589-611, July.
    • Handle: RePEc:spr:drugsa:v:39:y:2016:i:7:d:10.1007_s40264-016-0420-2
    DOI: 10.1007/s40264-016-0420-2
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40264-016-0420-2
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40264-016-0420-2?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:drugsa:v:39:y:2016:i:7:d:10.1007_s40264-016-0420-2. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com/economics/journal/40264 .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.